Records containing: Systemic Lupus Erythematosus
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-12-04Characterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune Deficiencies
-
CLINICAL_TRIALS study record update · 2025-12-03Ferroptosis Role in the Pathophysiology of Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-12-03A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants With Active Systemic Lupus Erythematosus (SLE) (POETYK SLE-1)
-
CLINICAL_TRIALS study record update · 2025-12-03Efficacy, Immunogenicity and Safety of Recombinant Vaccine Against Herpes Zoster (RZV or SHINGRIX®) in Patients With Autoimmune Rheumatic Diseases
-
CLINICAL_TRIALS study record update · 2025-12-02A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants With Active Systemic Lupus Erythematosus (SLE) (POETYK SLE-2)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-12-01A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging, Parallel and Adaptive Study to Evaluate the Efficacy and Safety of Enpatoran in SLE and in CLE (SCLE and/or DLE) Participants Receiving Standard of Care (WILLOW)
-
CLINICAL_TRIALS study record update · 2025-11-26A Phase 4, Multicenter, Prospective, Open-Label Study Describing the Efficacy and Safety of Belimumab Administered Subcutaneously in Adult Participants With Early Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-11-25A Phase 1 Study Evaluating SC291, a Hypoimmune, Allogeneic CD19-directed CAR T Cell Therapy, in Subjects With Severe Relapsed or Refractory Autoimmune Diseases (GLEAM)
-
CLINICAL_TRIALS study record update · 2025-11-20Safety and Efficacy of ONTO1 in Lupus
-
CLINICAL_TRIALS study record update · 2025-11-19Evaluation of the Clinical Outcome of Probiotics in Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-11-18Study of Ultra-Fast Autologous CD19-targeted Chimeric Antigen Receptor T (CAR- T) Therapy for Refractory Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-11-14A Multi-Centre, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Subcutaneously Administered Belimumab Plus Standard Therapy in Chinese Pediatric Participants With Systemic Lupus Erythematosus (SLE)
-
CLINICAL_TRIALS study record update · 2025-11-12Breaking Implicit Bias Habits: An Individuation Pilot to Promote Equity in Rheumatic Disease Care
-
CLINICAL_TRIALS study record update · 2025-11-10Testing of an Educational Tool for Patients With Melanoma and Concomitant Autoimmune Disease Who Are Candidates for Adjuvant Therapy With Immune Checkpoint Inhibitors: Acceptability and Usability With Patients and Providers
-
CLINICAL_TRIALS study record update · 2025-11-04A Phase 1, Open-Label Study to Evaluate the Safety and Tolerability of a Combination Autologous CD19 CAR T Cell Therapy (SYNCAR-001 + STK-009) in Subjects With Severe, Refractory Systemic Autoimmune Rheumatic Disease
-
CLINICAL_TRIALS study record update · 2025-10-29ImmuneNet: Quantum-Synaptic Immunotherapy Mapping
-
CLINICAL_TRIALS study record update · 2025-10-14Autologous Hematopoietic Stem Cell Transplant for Children and Young Adults With Life Threatening Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2025-10-10Real World Evidence of Anifrolumab in Systemic Lupus Erythematosus: a Multicenter Spontaneous Observational Study Aimed at Evaluating the Efficacy and Safety of Anifrolumab in a Cohort of Patients With Active Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-10-10Implementing the Decision-Aid for Lupus (IDEAL Strategy)
-
CLINICAL_TRIALS study record update · 2025-10-03A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK3996401 Following Single and Multiple Ascending Doses of GSK4347859 in Healthy Participants
-
CLINICAL_TRIALS study record update · 2025-10-02A Pilot Study Evaluating the Effect and Feasibility of Virtual Reiki Therapy as a Complementary Treatment for Patients With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-09-30CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease
-
CLINICAL_TRIALS study record update · 2025-09-30Intervention to Improve Patient-provider Communication and Medication Adherence Among Patients With Systemic Lupus Erythematosus (SLE)
-
CLINICAL_TRIALS study record update · 2025-09-29A Clinical Study Evaluating the Safety and Preliminary Efficacy of Universal Allogeneic CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2025-09-26Vagus Nerve Stimulation as a Novel Treatment for Systemic Lupus Erythematous: A Double Blinded Randomized Controlled Trail